Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. We determined hepatitis B virus (HBV) suppression rates among 18 lamivudine (3TC)-experienced HBV-human immunodeficiency virus-coinfected adolescents after treatment with tenofovir disoproxil fumurate (TDF). At TDF initiation, their m...
Saved in:
Main Authors: | Linda Aurpibul, Pagakrong Lumbiganon, Rawiwan Hansudewechakul, Suparat Kanjanavanit, Torsak Bunupuradah, Pope Kosalaraksa, Pawinee Taeprasert, Thanyawee Puthanakit |
---|---|
Format: | Journal |
Published: |
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85007247655&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/47204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
by: Linda Aurpibul, et al.
Published: (2018) -
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
by: Aurpibul L., et al.
Published: (2017) -
HIV and hepatitis B coinfection among perinatally HIV-infected thai adolescents
by: Linda Aurpibul, et al.
Published: (2018) -
Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
by: Linda Aurpibul, et al.
Published: (2019) -
Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
by: Tavitiya Sudjaritruk, et al.
Published: (2018)